Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

(2022) Scott D. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global Differences in Heart Failure With Preserved Ejection Fraction

(2021) Jasper Tromp et al.   Circulation-Heart Failure

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

(2021) Stefan D. Anker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study

(2020) Camilla Hage et al.   JOURNAL OF CARDIAC FAILURE

Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF

(2018) Sanjiv J Shah et al.   EUROPEAN HEART JOURNAL

Endothelial function and cardiovascular events in chronic kidney disease

(2014) Yoshihiro Hirata et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

(2013) Walter J. Paulus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY